{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:43:59Z","timestamp":1787503439192,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.thromres.2013.12.032","type":"journal-article","created":{"date-parts":[[2014,1,4]],"date-time":"2014-01-04T10:46:04Z","timestamp":1388832364000},"page":"371-374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Residual vein thrombosis and onset of post-thrombotic syndrome: Influence of the 4G\/5G polymorphism of plasminogen activator inhibitor-1 gene"],"prefix":"10.1016","volume":"133","author":[{"given":"Egle","family":"Incalcaterra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Meli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Muratori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egle","family":"Corrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baldassare","family":"Canino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2013.12.032_bb0175","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000469153","article-title":"Plasminogen activator inhibitors \u2013 a review","volume":"40","author":"Kruithof","year":"1988","journal-title":"Enzyme"},{"key":"10.1016\/j.thromres.2013.12.032_bb0010","doi-asserted-by":"crossref","first-page":"17128","DOI":"10.1016\/S0021-9258(18)41903-5","article-title":"Plasminogen activator inhibitor-1 binds to fibrin and inhibits tissue-type plasminogen activator-mediated fibrin dissolution","volume":"267","author":"Reilly","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2013.12.032_bb0015","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1073\/pnas.92.6.1851","article-title":"Allele-specific increase in basal transcription of the plasminogen-activator inhibitor-1 gene associated with myocardial infarction","volume":"92","author":"Eriksson","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.thromres.2013.12.032_bb0020","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1055\/s-0037-1615105","article-title":"The 4G\/5G sequence polymorphism in the promoter of plasminogen activator inhibitor \u20131 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism","volume":"79","author":"Stegnar","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.12.032_bb0180","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1055\/s-2002-36699","article-title":"Increased expression of plasminogen activator inhibitor-1 with fibrin deposition in a murin model of aging, \u201cKlotho\u201d mouse","volume":"28","author":"Takeshita","year":"2002","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.thromres.2013.12.032_bb0030","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1055\/s-0037-1613409","article-title":"Stocholm Heart Epidemiology Program. PAI-1 level and PAI-1 4G\/5G polymorphism in relatioship to risk of non-fatal myocardial infarction: results from the Srockholm Heart Epidemiology program (SHEEP","volume":"89","author":"Leander","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.12.032_bb0035","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1160\/TH04-09-0560","article-title":"The plasminogen activator inhibitor (PAI-1) promoter polymorphism and PAI-1 levels in ischemic stroke. A case-control study","volume":"93","author":"van Goor","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.12.032_bb0040","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1161\/ATVBAHA.107.155556","article-title":"Plasminogen activator inhibitor polymorphism (4G\/5G) predicts recurrence in nonhyperlipidemic postinfarction patients","volume":"28","author":"Corsetti","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.thromres.2013.12.032_bb0045","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1161\/hc5001.100793","article-title":"Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review","volume":"104","author":"Boekholdt","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2013.12.032_bb0050","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000047656","article-title":"4G\/5G polymorphism of the Plasminogen Activator Inhibitor-1 gene and insertion\/deletion Polymorphism of the tissue-type plasminogen activator gene in atherothrombotic stroke","volume":"11","author":"Bang","year":"2001","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.thromres.2013.12.032_bb0055","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00043798-200204000-00009","article-title":"The association of PAI-1 promoter 4G\/5G insertion\/deletion polymorphism with myocardial infarction and stroke in young women","volume":"9","author":"Hindorff","year":"2002","journal-title":"J Cardiovasc Risk"},{"key":"10.1016\/j.thromres.2013.12.032_bb0060","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1161\/01.STR.0000128707.48644.7e","article-title":"Plasminogen activator inhibitor-1 4G allele in the 4G\/5G promoter polymorphism increase the occurrence of cerebral ischemia after aneurysma subarachnoid hemorrhage","volume":"35","author":"Vergouwen","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2013.12.032_bb0065","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/MBC.0b013e3281ec4eee","article-title":"Plasminogen activator inhibitor-1 4G\/5G polymorphism and risk of ischemic stroke: a meta-analusis","volume":"18","author":"Tsantes","year":"2007","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.thromres.2013.12.032_bb0070","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1161\/01.STR.0000098004.26252.EB","article-title":"4G\/4G genotype of PAI-1 gene is associated with reduced risk stroke in elderly","volume":"34","author":"Hoekstra","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2013.12.032_bb0075","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ejvs.2005.05.038","article-title":"Genetic polymorphism and risk of recurrent deep venous thrombosis in young people: prospective cohort study","volume":"30","author":"Mansilha","year":"2005","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.thromres.2013.12.032_bb0080","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0049-3848(96)00211-3","article-title":"A novel G\/A and 4G\/5G polymorphism within the promoter of the plasminogen activator inhibitor-1 gene in patients with deep vein thrombosis","volume":"84","author":"Grubic","year":"1996","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2013.12.032_bb0085","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1161\/01.CIR.95.1.59","article-title":"Arterial and venous thrombosis is not associated with 4G75g polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men","volume":"95","author":"Ridker","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2013.12.032_bb0090","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0049-3848(00)00236-X","article-title":"The role of the t-PA I\/D and PAI-1 4G\/5G plymorphisms in African-American adults with a diagnosis of myocardial infarction or venous thromboembolism","volume":"99","author":"Hooper","year":"2000","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2013.12.032_bb0095","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/346074a0","article-title":"Development of venous thromboembolism in mice transgenic for the plasminogen activator inhibitor \u20131 gene","volume":"346","author":"Erickson","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.thromres.2013.12.032_bb0100","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/MBC.0b013e328359f618","article-title":"The association between the 4G\/5g polymorphism in the promoter of the plasminogen activator inhibitor gene and extension of post-surgical calf vein thrombosis","volume":"24","author":"Ferrara","year":"2013","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.thromres.2013.12.032_bb0105","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1182\/blood.V95.5.1517.005k48_1517_1532","article-title":"Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease","volume":"95","author":"Laane","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.12.032_bb0110","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/mp.53.6.300","article-title":"Thrombophilia polymorphisms and vascular disease","volume":"53","author":"Sykes","year":"2000","journal-title":"Mol Pathol"},{"key":"10.1016\/j.thromres.2013.12.032_bb0115","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2165\/00002512-199710040-00006","article-title":"Nadroparin calcium. A review of its pharmacologoical and clinical use in the prevention and treatment of thromboembolic disorders","volume":"10","author":"Davis","year":"1997","journal-title":"Drugs Aging"},{"key":"10.1016\/j.thromres.2013.12.032_bb0120","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1055\/s-0037-1614365","article-title":"Hemostatic activation under anticoagulant treatment: a comparison of unfractionated heparin vs. Nadroparin in the treatment of proximal deep vein thrombosis","volume":"82","author":"Stricker","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.12.032_bb0125","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1159\/000051969","article-title":"Efficacy and safety of weight-adapted nadroparin calcium vs. Heparin sodium in prevention of clinically evident thromboembolic complications in 1.990 general surgical patients","volume":"17","author":"Egger","year":"2000","journal-title":"Dig Surg"},{"key":"10.1016\/j.thromres.2013.12.032_bb0130","first-page":"515","article-title":"Normalization rates of compression ultrasonography in patients with a first episode of deep vein thrombosis of the lower limbs: association with DVT recurrence and new thrombosis","volume":"87","author":"Piovella","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2013.12.032_bb0135","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1182\/blood-2008-01-131656","article-title":"Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression UltraSonography (DACUS) study","volume":"112","author":"Siragusa","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.12.032_bb0140","doi-asserted-by":"crossref","first-page":"10739","DOI":"10.1016\/S0021-9258(18)82047-6","article-title":"The two allele sequences of a common polymorphism im the promoter of the plasminogen activator inhibitor-1 (PAI-1) egne respond differently to interleukin-1 in HepG2 cells","volume":"268","author":"Dawson","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2013.12.032_bb0145","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1055\/s-0038-1651064","article-title":"Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis","volume":"57","author":"Juhan-Vague","year":"1987","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.12.032_bb0150","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1046\/j.1365-2141.2000.02321.x","article-title":"PAI-1 promoter 4G\/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects","volume":"111","author":"Segui","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2013.12.032_bb0155","first-page":"624","article-title":"Association of 4G\/5G polymorphism in PAI1 promoter with PAI 1 level in deep vein thrombosis","volume":"22","author":"Chen","year":"2005","journal-title":"Zhonghua Yi Xue Yi Chuan Za Zhi"},{"key":"10.1016\/j.thromres.2013.12.032_bb0160","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1055\/s-0038-1649833","article-title":"The 4G\/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study","volume":"74","author":"Ye","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.12.032_bb0165","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1055\/s-0037-1615395","article-title":"4G\/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis","volume":"80","author":"Sartori","year":"1998","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.thromres.2013.12.032_bb0170","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.thromres.2012.06.015","article-title":"Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis","volume":"130","author":"Gong","year":"2012","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.thromres.2013.12.032_bb0185","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/MCA.0b013e3283576a77","article-title":"PAI-1 4G\/5G gene polymorphism is associated with angiographic patency in ST-elevation myocardial infarction patients treated with thrombolytic therapy","volume":"23","author":"Ozkan","year":"2012","journal-title":"Coron Artery Dis"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938481300618X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938481300618X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T11:03:34Z","timestamp":1647860614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004938481300618X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S004938481300618X"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2013.12.032","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Residual vein thrombosis and onset of post-thrombotic syndrome: Influence of the 4G\/5G polymorphism of plasminogen activator inhibitor-1 gene","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2013.12.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}